TriMas Corporation — Q1 2022 Form 10-Q Summary
Business context and reporting period
TriMas designs and manufactures engineered products serving consumer products, aerospace and defense, and industrial markets through its Packaging, Aerospace, and Specialty Products segments. This unaudited quarterly report covers the three months ended March 31, 2022, compared with the three months ended March 31, 2021.
Financial performance and key metrics
| Metric | Q1 2022 | Q1 2021 | Change |
|---|---|---|---|
| Net sales | $224.3 million | $206.7 million | +8.5% |
| Gross profit | $53.7 million | $51.3 million | +4.6% |
| Gross margin | 23.9% | 24.8% | Down 90 basis points |
| Operating profit | $21.9 million | $21.1 million | +3.9% |
| Operating margin | 9.8% | 10.2% | Down 40 basis points |
| Net income | $14.2 million | $13.1 million | +8.5% |
| Diluted EPS | $0.33 | $0.30 | +10.0% |
| Cash flow from operations | $5.7 million | $15.7 million | Down $10.1 million |
Sales growth reflected approximately $9.0 million from acquisitions and approximately $11.0 million of organic growth, partly offset by a $2.4 million unfavorable currency effect. Packaging sales increased 4.8% to $138.5 million, Aerospace sales were essentially flat at $44.5 million, and Specialty Products sales increased 37.5% to $41.3 million.
Operating results benefited from higher sales, lower realignment costs, improved resin-cost recovery, and lower interest and other expense. These benefits were partly offset by unfavorable mix, approximately $2.0 million of higher energy and utility costs, higher Packaging selling and administrative expenses, and a higher effective tax rate of 22.3% versus 20.5%.
Liquidity, debt, and capital allocation
- Cash and cash equivalents were $58.8 million at March 31, 2022, including $5.1 million of restricted cash, versus $140.7 million at year-end 2021.
- Long-term debt, net of issuance costs, was $394.0 million. The debt consisted primarily of $400.0 million of 4.125% senior notes due April 2029.
- The $300.0 million revolving credit facility had no borrowings outstanding and approximately $300.0 million of availability. The company was in compliance with its debt covenants.
- Actual total net leverage was 1.98x against a 4.00x covenant limit; interest coverage was 13.73x against a 3.00x minimum.
- Investing cash use was $75.8 million, including $64.0 million for the acquisition of Intertech Plastics and $11.9 million of capital expenditures.
- The company repurchased 282,003 shares for approximately $9.1 million and had approximately $133.6 million remaining under its repurchase authorization. It also paid $1.7 million of dividends, or $0.04 per share.
Material changes versus the prior comparable period
- TriMas acquired Intertech Plastics on February 28, 2022, for approximately $64.0 million net of cash acquired. Intertech contributed approximately $2.8 million of Q1 sales and added approximately $32.2 million of goodwill and $13.5 million of intangible assets.
- Recent acquisitions of Omega Plastics and TFI Aerospace contributed approximately $4.8 million and $1.4 million of Q1 sales, respectively.
- Specialty Products benefited from stronger industrial, cylinder, engine, compressor, and oil-field demand, while Aerospace profitability declined materially because of lower-margin product mix and reduced customer stocking orders.
- COVID-related demand for Packaging dispensing products used in hygiene applications declined approximately $14.5 million from the prior-year peak, while food and beverage and industrial Packaging sales increased.
- Realignment charges declined to approximately $2.3 million from $4.1 million in Q1 2021. The 2022 charges included employee-related, facility move, consolidation, and benefit-plan reorganization costs.
- Working-capital usage increased, particularly from a $22.3 million increase in receivables, contributing to the decline in operating cash flow.
Guidance, outlook, commentary, and risks
The filing does not provide a specific full-year quantitative revenue or earnings guidance figure. Management expects continued uncertainty in aerospace production rates, industrial demand, COVID-19 developments, labor availability, supply chains, commodity costs, and energy prices. The Russia-Ukraine conflict and related energy-supply constraints increased European energy costs and may create additional cost and supply-chain pressure.
Management expects to pursue pricing, sourcing, continuous-improvement, and footprint actions to offset inflationary pressures. It also expects to continue evaluating acquisitions, capital expenditures, dividends, and share repurchases. Management believes liquidity and covenant headroom are sufficient to fund debt service, capital expenditures, working capital, dividends, and repurchases for the foreseeable future.
Material contingencies include 4,782 pending asbestos claims involving 407 cases. Asbestos-related liabilities totaled $27.2 million at March 31, 2022; management stated that the claims are not expected to have a material adverse effect on financial position, results, or cash flows. Other principal risks include foreign-exchange exposure, interest-rate volatility, leverage, customer demand, raw-material availability and pricing, labor shortages, cyber risks, acquisitions and integration, litigation, and potential impairment of goodwill or other intangible assets.
Unusual items included $2.3 million of realignment charges, a non-cash pension curtailment expense of approximately $0.2 million, acquisition-related purchase accounting, and other comprehensive losses of $2.2 million, primarily from foreign-currency translation.
Important facts for investors to verify
- Whether Aerospace demand and margins recover as aircraft production and customer orders improve.
- Whether pricing and productivity actions offset energy, labor, raw-material, and logistics inflation.
- Intertech, Omega, and TFI integration progress, earnings contribution, and any required contingent consideration.
- Cash conversion and working-capital trends, particularly receivables and inventory.
- Compliance with the 2029 senior-note and revolving-credit covenants as acquisitions and shareholder returns continue.
- The potential range and timing of future asbestos claims, settlements, defense costs, and insurance recovery.
- The effect of COVID-19 restrictions, geopolitical developments, currency movements, and supply disruptions on operations.
- The amount and timing of future dividends and share repurchases, which remain subject to board approval and market conditions.